Blog

Regeneus extends reach of HiQCell® stem cell therapy to Melbourne – Proactive Investors Australia

Proactive Investors Australia
Regenerative medicine company Regeneus (ASX: RGS) has started offering its HiQCell

2013-10-30 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.